FibroGen, Inc. (FGEN)
NASDAQ: FGEN · Real-Time Price · USD
12.11
+0.79 (7.03%)
Sep 5, 2025, 3:10 PM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Novel Therapeutics
29.62M
Log In
Log In
Log In
Log In
Upgrade
Novel Therapeutics Growth
-79.95%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
United States
26.11M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
101.48%
Log In
Log In
Log In
Log In
Upgrade
Europe
6.27M
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
-34.34%
Log In
Log In
Log In
Log In
Upgrade
China
91.00K
Log In
Log In
Log In
Log In
Upgrade
China Growth
-99.92%
Log In
Log In
Log In
Log In
Upgrade
Japan
-2.85M
Log In
Log In
Log In
Log In
Upgrade
Japan Growth
-117.99%
Log In
Log In
Log In
Log In
Upgrade